As a copathology to AD, accounting for the presence of LB pathology may also be relevant when examining the cognitive trajectories of preclinical individuals in observational studies according to the AD framework that characterizes the presence of Aβ (A), tau (T) and non-AD specific neurodegeneration (N) for diagnosis12 and prognosis13. This evidence concerns the gene MAPT and Alzheimer disease.